Backed By Science, Proven By Research: Clinical Pharmacists Impacting Patient Outcomes with MedWise Science and MedWise Risk Score

Clinical Evidence | 2 Minute Read

Clinical Pharmacists Impacting Patient Outcomes with MedWise® Science and MedWise Risk ScoreTM

New research!
4 years in the making

TRHC is proud to present groundbreaking insights from years of pharmacist-led interventions and peer-reviewed research.

In 2017, Tabula Rasa HealthCare (TRHC) began participating in the Center for Medicaid and Medicare Services (CMS) Innovation Center’s five-year Enhanced Medication Therapy Management (MTM) model. TRHC collaborated with pharmacies across the Midwest to provide personalized consultations to patients at risk for medication-related issues.* Under the Enhanced MTM model, collaborating pharmacy teams used the MedWise Risk Score™ to target patients at risk for medication-related problems. Using medication decision support tools powered by MedWise® Science, pharmacists provided actionable insights to reduce patient risk, resulting in improved health outcomes and reduced medical costs. 

TRHC’s multifaceted Research and Development team has compiled insights from the pharmacist-led model into three peer-reviewed articles, recently published in a supplement by the American Journal of Managed Care (AJMC).

“After speaking with a pharmacist, I talked with my mom’s doctor about separating her medication times. Once this change was made, I noticed that my mother seemed to be in less pain and her depressive symptoms improved greatly.”

– David, caregiver

*In the Enhanced MTM model, TRHC serves Part D Region 25, which includes the following states: Iowa, Minnesota, Montana, Nebraska, North Dakota, South Dakota, and Wyoming.

Share this:
Fill 1 Copy 2closeFill 5 Copy 4green-arrowhamburgerFill 7 Copy 4Fill 1 Copy 4pauseplaysearch-iconFill 3 Copy 4